Global Connected Injectable Drug Delivery Devices Market Research Report 2023

Report ID: 1993251 | Published Date: Jan 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Connected Injectable Drug Delivery Devices Market Overview
    1.1 Product Overview and Scope of Connected Injectable Drug Delivery Devices
    1.2 Connected Injectable Drug Delivery Devices Segment by Type
        1.2.1 Global Connected Injectable Drug Delivery Devices Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Conventional Injection Devices
        1.2.3 Self-Injection Devices
        1.2.4 Others
    1.3 Connected Injectable Drug Delivery Devices Segment by Application
        1.3.1 Global Connected Injectable Drug Delivery Devices Sales Comparison by Application: (2022-2028)
        1.3.2 Diabetes
        1.3.3 Cardiovascular Diseases
        1.3.4 Autoimmune Diseases
        1.3.5 Hormones Replacement
        1.3.6 Neurology
        1.3.7 Addiction
        1.3.8 Respiratory Diseases
        1.3.9 Others
    1.4 Global Connected Injectable Drug Delivery Devices Market Size Estimates and Forecasts
        1.4.1 Global Connected Injectable Drug Delivery Devices Revenue 2017-2028
        1.4.2 Global Connected Injectable Drug Delivery Devices Sales 2017-2028
        1.4.3 Connected Injectable Drug Delivery Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Connected Injectable Drug Delivery Devices Market Competition by Manufacturers
    2.1 Global Connected Injectable Drug Delivery Devices Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Connected Injectable Drug Delivery Devices Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Connected Injectable Drug Delivery Devices Manufacturing Sites, Area Served, Product Type
    2.5 Connected Injectable Drug Delivery Devices Market Competitive Situation and Trends
        2.5.1 Connected Injectable Drug Delivery Devices Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Connected Injectable Drug Delivery Devices Players Market Share by Revenue
        2.5.3 Global Connected Injectable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Connected Injectable Drug Delivery Devices Retrospective Market Scenario by Region
    3.1 Global Connected Injectable Drug Delivery Devices Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Connected Injectable Drug Delivery Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Connected Injectable Drug Delivery Devices Market Facts & Figures by Country
        3.3.1 North America Connected Injectable Drug Delivery Devices Sales by Country
        3.3.2 North America Connected Injectable Drug Delivery Devices Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Connected Injectable Drug Delivery Devices Market Facts & Figures by Country
        3.4.1 Europe Connected Injectable Drug Delivery Devices Sales by Country
        3.4.2 Europe Connected Injectable Drug Delivery Devices Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Connected Injectable Drug Delivery Devices Market Facts & Figures by Region
        3.5.1 Asia Pacific Connected Injectable Drug Delivery Devices Sales by Region
        3.5.2 Asia Pacific Connected Injectable Drug Delivery Devices Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Connected Injectable Drug Delivery Devices Market Facts & Figures by Country
        3.6.1 Latin America Connected Injectable Drug Delivery Devices Sales by Country
        3.6.2 Latin America Connected Injectable Drug Delivery Devices Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Connected Injectable Drug Delivery Devices Market Facts & Figures by Country
        3.7.1 Middle East and Africa Connected Injectable Drug Delivery Devices Sales by Country
        3.7.2 Middle East and Africa Connected Injectable Drug Delivery Devices Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Connected Injectable Drug Delivery Devices Historic Market Analysis by Type
    4.1 Global Connected Injectable Drug Delivery Devices Sales Market Share by Type (2017-2022)
    4.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Type (2017-2022)
    4.3 Global Connected Injectable Drug Delivery Devices Price by Type (2017-2022)
5 Global Connected Injectable Drug Delivery Devices Historic Market Analysis by Application
    5.1 Global Connected Injectable Drug Delivery Devices Sales Market Share by Application (2017-2022)
    5.2 Global Connected Injectable Drug Delivery Devices Revenue Market Share by Application (2017-2022)
    5.3 Global Connected Injectable Drug Delivery Devices Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Phillips-Medisize
        6.1.1 Phillips-Medisize Corporation Information
        6.1.2 Phillips-Medisize Description and Business Overview
        6.1.3 Phillips-Medisize Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Phillips-Medisize Connected Injectable Drug Delivery Devices Product Portfolio
        6.1.5 Phillips-Medisize Recent Developments/Updates
    6.2 West Pharmaceutical Services
        6.2.1 West Pharmaceutical Services Corporation Information
        6.2.2 West Pharmaceutical Services Description and Business Overview
        6.2.3 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 West Pharmaceutical Services Connected Injectable Drug Delivery Devices Product Portfolio
        6.2.5 West Pharmaceutical Services Recent Developments/Updates
    6.3 Biocorp
        6.3.1 Biocorp Corporation Information
        6.3.2 Biocorp Description and Business Overview
        6.3.3 Biocorp Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Biocorp Connected Injectable Drug Delivery Devices Product Portfolio
        6.3.5 Biocorp Recent Developments/Updates
    6.4 Aterica
        6.4.1 Aterica Corporation Information
        6.4.2 Aterica Description and Business Overview
        6.4.3 Aterica Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Aterica Connected Injectable Drug Delivery Devices Product Portfolio
        6.4.5 Aterica Recent Developments/Updates
    6.5 Unilife
        6.5.1 Unilife Corporation Information
        6.5.2 Unilife Description and Business Overview
        6.5.3 Unilife Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Unilife Connected Injectable Drug Delivery Devices Product Portfolio
        6.5.5 Unilife Recent Developments/Updates
    6.6 Propeller Health
        6.6.1 Propeller Health Corporation Information
        6.6.2 Propeller Health Description and Business Overview
        6.6.3 Propeller Health Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Propeller Health Connected Injectable Drug Delivery Devices Product Portfolio
        6.6.5 Propeller Health Recent Developments/Updates
    6.7 Haselmeier
        6.6.1 Haselmeier Corporation Information
        6.6.2 Haselmeier Description and Business Overview
        6.6.3 Haselmeier Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Haselmeier Connected Injectable Drug Delivery Devices Product Portfolio
        6.7.5 Haselmeier Recent Developments/Updates
    6.8 SHL
        6.8.1 SHL Corporation Information
        6.8.2 SHL Description and Business Overview
        6.8.3 SHL Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 SHL Connected Injectable Drug Delivery Devices Product Portfolio
        6.8.5 SHL Recent Developments/Updates
    6.9 Becton Dickinson
        6.9.1 Becton Dickinson Corporation Information
        6.9.2 Becton Dickinson Description and Business Overview
        6.9.3 Becton Dickinson Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Becton Dickinson Connected Injectable Drug Delivery Devices Product Portfolio
        6.9.5 Becton Dickinson Recent Developments/Updates
    6.10 Baxter International
        6.10.1 Baxter International Corporation Information
        6.10.2 Baxter International Description and Business Overview
        6.10.3 Baxter International Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Baxter International Connected Injectable Drug Delivery Devices Product Portfolio
        6.10.5 Baxter International Recent Developments/Updates
    6.11 Scandinavian Health
        6.11.1 Scandinavian Health Corporation Information
        6.11.2 Scandinavian Health Connected Injectable Drug Delivery Devices Description and Business Overview
        6.11.3 Scandinavian Health Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Scandinavian Health Connected Injectable Drug Delivery Devices Product Portfolio
        6.11.5 Scandinavian Health Recent Developments/Updates
    6.12 Ypsomed
        6.12.1 Ypsomed Corporation Information
        6.12.2 Ypsomed Connected Injectable Drug Delivery Devices Description and Business Overview
        6.12.3 Ypsomed Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Ypsomed Connected Injectable Drug Delivery Devices Product Portfolio
        6.12.5 Ypsomed Recent Developments/Updates
    6.13 Terumo Medical
        6.13.1 Terumo Medical Corporation Information
        6.13.2 Terumo Medical Connected Injectable Drug Delivery Devices Description and Business Overview
        6.13.3 Terumo Medical Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Terumo Medical Connected Injectable Drug Delivery Devices Product Portfolio
        6.13.5 Terumo Medical Recent Developments/Updates
    6.14 Schott
        6.14.1 Schott Corporation Information
        6.14.2 Schott Connected Injectable Drug Delivery Devices Description and Business Overview
        6.14.3 Schott Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Schott Connected Injectable Drug Delivery Devices Product Portfolio
        6.14.5 Schott Recent Developments/Updates
    6.15 Owen Mumford
        6.15.1 Owen Mumford Corporation Information
        6.15.2 Owen Mumford Connected Injectable Drug Delivery Devices Description and Business Overview
        6.15.3 Owen Mumford Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Owen Mumford Connected Injectable Drug Delivery Devices Product Portfolio
        6.15.5 Owen Mumford Recent Developments/Updates
    6.16 Antares Pharma
        6.16.1 Antares Pharma Corporation Information
        6.16.2 Antares Pharma Connected Injectable Drug Delivery Devices Description and Business Overview
        6.16.3 Antares Pharma Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 Antares Pharma Connected Injectable Drug Delivery Devices Product Portfolio
        6.16.5 Antares Pharma Recent Developments/Updates
    6.17 Zogenix
        6.17.1 Zogenix Corporation Information
        6.17.2 Zogenix Connected Injectable Drug Delivery Devices Description and Business Overview
        6.17.3 Zogenix Connected Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Zogenix Connected Injectable Drug Delivery Devices Product Portfolio
        6.17.5 Zogenix Recent Developments/Updates
7 Connected Injectable Drug Delivery Devices Manufacturing Cost Analysis
    7.1 Connected Injectable Drug Delivery Devices Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Connected Injectable Drug Delivery Devices
    7.4 Connected Injectable Drug Delivery Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Connected Injectable Drug Delivery Devices Distributors List
    8.3 Connected Injectable Drug Delivery Devices Customers
9 Connected Injectable Drug Delivery Devices Market Dynamics
    9.1 Connected Injectable Drug Delivery Devices Industry Trends
    9.2 Connected Injectable Drug Delivery Devices Market Drivers
    9.3 Connected Injectable Drug Delivery Devices Market Challenges
    9.4 Connected Injectable Drug Delivery Devices Market Restraints
10 Global Market Forecast
    10.1 Connected Injectable Drug Delivery Devices Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Connected Injectable Drug Delivery Devices by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Connected Injectable Drug Delivery Devices by Type (2023-2028)
    10.2 Connected Injectable Drug Delivery Devices Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Connected Injectable Drug Delivery Devices by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Connected Injectable Drug Delivery Devices by Application (2023-2028)
    10.3 Connected Injectable Drug Delivery Devices Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Connected Injectable Drug Delivery Devices by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Connected Injectable Drug Delivery Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Connected Injectable Drug Delivery Devices Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Connected Injectable Drug Delivery Devices Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Connected Injectable Drug Delivery Devices Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Connected Injectable Drug Delivery Devices Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Connected Injectable Drug Delivery Devices Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Connected Injectable Drug Delivery Devices Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Connected Injectable Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Connected Injectable Drug Delivery Devices Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Connected Injectable Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Connected Injectable Drug Delivery Devices Manufacturing Sites and Area Served
    Table 11. Manufacturers Connected Injectable Drug Delivery Devices Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Connected Injectable Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Connected Injectable Drug Delivery Devices as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Connected Injectable Drug Delivery Devices Sales by Region (2017-2022) & (K Units)
    Table 16. Global Connected Injectable Drug Delivery Devices Sales Market Share by Region (2017-2022)
    Table 17. Global Connected Injectable Drug Delivery Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Region (2017-2022)
    Table 19. North America Connected Injectable Drug Delivery Devices Sales by Country (2017-2022) & (K Units)
    Table 20. North America Connected Injectable Drug Delivery Devices Sales Market Share by Country (2017-2022)
    Table 21. North America Connected Injectable Drug Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Connected Injectable Drug Delivery Devices Revenue Market Share by Country (2017-2022)
    Table 23. Europe Connected Injectable Drug Delivery Devices Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Connected Injectable Drug Delivery Devices Sales Market Share by Country (2017-2022)
    Table 25. Europe Connected Injectable Drug Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Connected Injectable Drug Delivery Devices Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Connected Injectable Drug Delivery Devices Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Connected Injectable Drug Delivery Devices Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Connected Injectable Drug Delivery Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Connected Injectable Drug Delivery Devices Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Connected Injectable Drug Delivery Devices Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Connected Injectable Drug Delivery Devices Sales Market Share by Country (2017-2022)
    Table 33. Latin America Connected Injectable Drug Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Connected Injectable Drug Delivery Devices Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Connected Injectable Drug Delivery Devices Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Connected Injectable Drug Delivery Devices Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Connected Injectable Drug Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Connected Injectable Drug Delivery Devices Revenue Market Share by Country (2017-2022)
    Table 39. Global Connected Injectable Drug Delivery Devices Sales by Type (2017-2022) & (K Units)
    Table 40. Global Connected Injectable Drug Delivery Devices Sales Market Share by Type (2017-2022)
    Table 41. Global Connected Injectable Drug Delivery Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Connected Injectable Drug Delivery Devices Revenue Share by Type (2017-2022)
    Table 43. Global Connected Injectable Drug Delivery Devices Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Connected Injectable Drug Delivery Devices Sales (K Units) by Application (2017-2022)
    Table 45. Global Connected Injectable Drug Delivery Devices Sales Market Share by Application (2017-2022)
    Table 46. Global Connected Injectable Drug Delivery Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Connected Injectable Drug Delivery Devices Revenue Share by Application (2017-2022)
    Table 48. Global Connected Injectable Drug Delivery Devices Price by Application (2017-2022) & (USD/Unit)
    Table 49. Phillips-Medisize Corporation Information
    Table 50. Phillips-Medisize Description and Business Overview
    Table 51. Phillips-Medisize Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Phillips-Medisize Connected Injectable Drug Delivery Devices Product
    Table 53. Phillips-Medisize Recent Developments/Updates
    Table 54. West Pharmaceutical Services Corporation Information
    Table 55. West Pharmaceutical Services Description and Business Overview
    Table 56. West Pharmaceutical Services Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. West Pharmaceutical Services Connected Injectable Drug Delivery Devices Product
    Table 58. West Pharmaceutical Services Recent Developments/Updates
    Table 59. Biocorp Corporation Information
    Table 60. Biocorp Description and Business Overview
    Table 61. Biocorp Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Biocorp Connected Injectable Drug Delivery Devices Product
    Table 63. Biocorp Recent Developments/Updates
    Table 64. Aterica Corporation Information
    Table 65. Aterica Description and Business Overview
    Table 66. Aterica Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. Aterica Connected Injectable Drug Delivery Devices Product
    Table 68. Aterica Recent Developments/Updates
    Table 69. Unilife Corporation Information
    Table 70. Unilife Description and Business Overview
    Table 71. Unilife Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Unilife Connected Injectable Drug Delivery Devices Product
    Table 73. Unilife Recent Developments/Updates
    Table 74. Propeller Health Corporation Information
    Table 75. Propeller Health Description and Business Overview
    Table 76. Propeller Health Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 77. Propeller Health Connected Injectable Drug Delivery Devices Product
    Table 78. Propeller Health Recent Developments/Updates
    Table 79. Haselmeier Corporation Information
    Table 80. Haselmeier Description and Business Overview
    Table 81. Haselmeier Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 82. Haselmeier Connected Injectable Drug Delivery Devices Product
    Table 83. Haselmeier Recent Developments/Updates
    Table 84. SHL Corporation Information
    Table 85. SHL Description and Business Overview
    Table 86. SHL Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. SHL Connected Injectable Drug Delivery Devices Product
    Table 88. SHL Recent Developments/Updates
    Table 89. Becton Dickinson Corporation Information
    Table 90. Becton Dickinson Description and Business Overview
    Table 91. Becton Dickinson Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 92. Becton Dickinson Connected Injectable Drug Delivery Devices Product
    Table 93. Becton Dickinson Recent Developments/Updates
    Table 94. Baxter International Corporation Information
    Table 95. Baxter International Description and Business Overview
    Table 96. Baxter International Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 97. Baxter International Connected Injectable Drug Delivery Devices Product
    Table 98. Baxter International Recent Developments/Updates
    Table 99. Scandinavian Health Corporation Information
    Table 100. Scandinavian Health Description and Business Overview
    Table 101. Scandinavian Health Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 102. Scandinavian Health Connected Injectable Drug Delivery Devices Product
    Table 103. Scandinavian Health Recent Developments/Updates
    Table 104. Ypsomed Corporation Information
    Table 105. Ypsomed Description and Business Overview
    Table 106. Ypsomed Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 107. Ypsomed Connected Injectable Drug Delivery Devices Product
    Table 108. Ypsomed Recent Developments/Updates
    Table 109. Terumo Medical Corporation Information
    Table 110. Terumo Medical Description and Business Overview
    Table 111. Terumo Medical Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 112. Terumo Medical Connected Injectable Drug Delivery Devices Product
    Table 113. Terumo Medical Recent Developments/Updates
    Table 114. Schott Corporation Information
    Table 115. Schott Description and Business Overview
    Table 116. Schott Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 117. Schott Connected Injectable Drug Delivery Devices Product
    Table 118. Schott Recent Developments/Updates
    Table 119. Owen Mumford Corporation Information
    Table 120. Owen Mumford Description and Business Overview
    Table 121. Owen Mumford Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 122. Owen Mumford Connected Injectable Drug Delivery Devices Product
    Table 123. Owen Mumford Recent Developments/Updates
    Table 124. Antares Pharma Corporation Information
    Table 125. Antares Pharma Description and Business Overview
    Table 126. Antares Pharma Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 127. Antares Pharma Connected Injectable Drug Delivery Devices Product
    Table 128. Antares Pharma Recent Developments/Updates
    Table 129. Zogenix Corporation Information
    Table 130. Zogenix Description and Business Overview
    Table 131. Zogenix Connected Injectable Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 132. Zogenix Connected Injectable Drug Delivery Devices Product
    Table 133. Zogenix Recent Developments/Updates
    Table 134. Production Base and Market Concentration Rate of Raw Material
    Table 135. Key Suppliers of Raw Materials
    Table 136. Connected Injectable Drug Delivery Devices Distributors List
    Table 137. Connected Injectable Drug Delivery Devices Customers List
    Table 138. Connected Injectable Drug Delivery Devices Market Trends
    Table 139. Connected Injectable Drug Delivery Devices Market Drivers
    Table 140. Connected Injectable Drug Delivery Devices Market Challenges
    Table 141. Connected Injectable Drug Delivery Devices Market Restraints
    Table 142. Global Connected Injectable Drug Delivery Devices Sales Forecast by Type (2023-2028) & (K Units)
    Table 143. Global Connected Injectable Drug Delivery Devices Sales Market Share Forecast by Type (2023-2028)
    Table 144. Global Connected Injectable Drug Delivery Devices Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 145. Global Connected Injectable Drug Delivery Devices Revenue Market Share Forecast by Type (2023-2028)
    Table 146. Global Connected Injectable Drug Delivery Devices Sales Forecast by Application (2023-2028) & (K Units)
    Table 147. Global Connected Injectable Drug Delivery Devices Sales Market Share Forecast by Application (2023-2028)
    Table 148. Global Connected Injectable Drug Delivery Devices Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 149. Global Connected Injectable Drug Delivery Devices Revenue Market Share Forecast by Application (2023-2028)
    Table 150. Global Connected Injectable Drug Delivery Devices Sales Forecast by Region (2023-2028) & (K Units)
    Table 151. Global Connected Injectable Drug Delivery Devices Sales Market Share Forecast by Region (2023-2028)
    Table 152. Global Connected Injectable Drug Delivery Devices Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 153. Global Connected Injectable Drug Delivery Devices Revenue Market Share Forecast by Region (2023-2028)
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Connected Injectable Drug Delivery Devices
    Figure 2. Global Connected Injectable Drug Delivery Devices Market Share by Type in 2021 & 2028
    Figure 3. Conventional Injection Devices Product Picture
    Figure 4. Self-Injection Devices Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Connected Injectable Drug Delivery Devices Market Share by Application in 2021 & 2028
    Figure 7. Diabetes
    Figure 8. Cardiovascular Diseases
    Figure 9. Autoimmune Diseases
    Figure 10. Hormones Replacement
    Figure 11. Neurology
    Figure 12. Addiction
    Figure 13. Respiratory Diseases
    Figure 14. Others
    Figure 15. Global Connected Injectable Drug Delivery Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Connected Injectable Drug Delivery Devices Market Size (2017-2028) & (US$ Million)
    Figure 17. Global Connected Injectable Drug Delivery Devices Sales (2017-2028) & (K Units)
    Figure 18. Connected Injectable Drug Delivery Devices Sales Share by Manufacturers in 2021
    Figure 19. Global Connected Injectable Drug Delivery Devices Revenue Share by Manufacturers in 2021
    Figure 20. The Global 5 and 10 Largest Connected Injectable Drug Delivery Devices Players: Market Share by Revenue in 2021
    Figure 21. Connected Injectable Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 22. Global Connected Injectable Drug Delivery Devices Sales Market Share by Region (2017-2022)
    Figure 23. Global Connected Injectable Drug Delivery Devices Sales Market Share by Region in 2021
    Figure 24. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Region (2017-2022)
    Figure 25. Global Connected Injectable Drug Delivery Devices Revenue Market Share by Region in 2021
    Figure 26. U.S. Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Canada Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Germany Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. France Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. U.K. Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Italy Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Russia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. China Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Japan Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. South Korea Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. India Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Australia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Taiwan Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Indonesia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Thailand Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Malaysia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Philippines Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Vietnam Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Mexico Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Brazil Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Argentina Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 47. Turkey Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 48. Saudi Arabia Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 49. UAE Connected Injectable Drug Delivery Devices Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 50. Sales Market Share of Connected Injectable Drug Delivery Devices by Type (2017-2022)
    Figure 51. Manufacturing Cost Structure of Connected Injectable Drug Delivery Devices
    Figure 52. Manufacturing Process Analysis of Connected Injectable Drug Delivery Devices
    Figure 53. Connected Injectable Drug Delivery Devices Industrial Chain Analysis
    Figure 54. Channels of Distribution
    Figure 55. Distributors Profiles
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Phillips-Medisize
West Pharmaceutical Services
Biocorp
Aterica
Unilife
Propeller Health
Haselmeier
SHL
Becton Dickinson
Baxter International
Scandinavian Health
Ypsomed
Terumo Medical
Schott
Owen Mumford
Antares Pharma
Zogenix
Frequently Asked Questions
Connected Injectable Drug Delivery Devices report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Connected Injectable Drug Delivery Devices report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Connected Injectable Drug Delivery Devices report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports